Examination of lipid metabolism-improving effects by taking a single dose of test beverage
- Conditions
- Healthy male/female adults
- Registration Number
- JPRN-UMIN000048886
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
(1) Subjects taking steadily (not less than 3 times a week) in the following affecting foods; health-specific, functional, health foods (related to blood pressure, blood stream, exercise fatigue, metabolism-improving, poor blood flow-improving, fat combustion and/or lipolysis), supplementary one, vitamin tablet and nutrient, with any difficulty in refraining from having those after the consent. (2) Subjects who have any difficulty in refraining from taking steadily (not less than 3 times a week) in affecting medicines (e.g., lipid metabolism), during this trial. (3) Subjects with any possibility of hindrance to this trial, owing to their allergic rhinitis. (4) Subjects with not less than 25.0 kg/m2 of BMI and not less than 100 cm2 of abdominal fat area, at the consent. (5) Subjects who take excessive alcohol. (6) Subjects having a habit of smoking. (7) Subjects who are now under other clinical tests, or partook in those within 4 weeks before this trial. (8) Subjects with current and/or previous medical history of serious diseases in heart, liver, kidney and/or digestive organs. (9) Pregnant, possibly pregnant, or lactating women. (10) Subjects suffering from severe anemia. (11) Subjects having drug and/or food allergy. (12) Subjects who donated over 0.2 L of their whole blood and/or blood components within a month before this trial. (13) Males who donated their whole blood (0.4 L) within the last 3 months to this trial. (14) Females who donated their whole blood (0.4 L) within the last 4 months to this trial. (15) Males who will be collected in total of their blood (1.2 L) within the last 12 months, after adding the blood amounts planning to be sampled in this trial. (16) Females who will be collected in total of their blood (0.8 L) within the last 12 months, after adding the blood amounts planning to be sampled in this trial. (17) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method